Navigation path

EU Health Research

In the spotlight

The "Health, demographic change and well-being" Work Programme 2016-2017 is online on the Participants' Portal
Scientific Panel for Health

European research and innovation in health is an investment in our health and, on a larger scale, in a healthy workforce, a healthy economy and lower public health bills.

EU funding and support helps health researchers to find new ways of preventing diseases, developing better diagnostics and more effective therapies, and taking up new models of care and technologies promoting health and well being. Read more...

Info Day, Horizon 2020

'Health, demographic change and wellbeing' - 18 September 2015

Presentations & video recordings

Financial instruments


ICT for Health, Wellbeing and Active and healthy Ageing


Type 1 diabetes research: taking stock and maximising collaboration

30 October 2015

The European Commission and the JDRF (formerly Juvenile Diabetes Research Foundation) jointly organised a workshop on type 1 diabetes with the ultimate goal of defining the state-of-art in the field, identifying gaps, and brainstorming about the possibilities offered by personalised medicine approaches in this area.

Launch of EU-CELAC Joint Initiative on Health Research and Innovation

29 October 2015

EU-LAC Health paving the way for the EU-CELAC Joint Initiative on Health Research and Innovation (JIRI-Health) towards the EU-CELAC Common Research Area.
The Event will take place on 23 November 2015 in Brussels, Belgium.

Together for the Next Generation, Research and Innovation for Maternal and Newborn Health - 8 December

25 August 2015

Research has a crucial role to play in improving the health of mothers and children, this being one of the priorities of the European Commission. Global coordination is essential to achieving health and wellbeing, particularly at this time of transition from MDGs to SDGs. Organised by the Directorate-General for Research and Innovation, the Research and Innovation for Maternal and Newborn Health Conference will take place on the 8 December in Brussels.

GACD funds landmark research into prevention and treatment of type 2 diabetes

20 August 2015

Members of the Global Alliance for Chronic Diseases will fund sixteen research projects to prevent and treat type 2 diabetes with over USD 30 million. The research is to take place in twenty-five low-and middle-income centres across the globe. Carlos Moedas, European Commissioner for Research, Science and Innovation, said: "Fighting a global problem requires a global effort and the European Commission is proud to contribute to the coordinated GACD initiative. Three research projects funded through Horizon 2020 and worth €10 million will help better control, manage and prevent the disease."

Dr Michael Makanga designated as next EDCTP Executive Director

14 July 2015

'During the last General Assembly of the European & Developing Countries Clinical Trials Partnership (EDCTP), Dr Michael Makanga was selected to succeed Professor Charles Mgone as Executive Director. Carlos Moedas, European Commissioner for Research, Science and Innovation, said: 'EDCTP is a flagship initiative under Horizon 2020 whose ambitious goals require commitment and leadership. Michael Makanga's invaluable experience will help EDCTP deliver and succeed on its objectives.'

First loan under InnovFin Infectious Diseases provides €10 million to improve HIV testing

13 July 2015

The European Investment Bank provided today a €10 million loan to Cavidi AB for the development of an automated version of its existing manual device for HIV viral load testing. This low cost testing device is proven to work in simplified less sophisticated laboratories thus allowing to perform, in a practical and affordable manner, regular assessment of HIV positive patients also in low-and middle-income countries.

EU response to the Ebola outbreak in West Africa

10 July 2015

The European Commission has promptly and strongly supported urgent Ebola research on potential treatments, vaccines and diagnostic tests with almost €140 million from Horizon 2020, the EU's research and innovation funding programme. Additionally, the European Commission and the European pharmaceutical industry are funding eight research projects on the development of vaccines and rapid diagnostics tests, which are key to overcoming the current Ebola crisis. These projects are run under the new 'Ebola+' programme of the Innovative Medicines Initiative (IMI) and funded with a total of €215 million, €114 million of which come from Horizon 2020. The factsheet was published on the occasion of the International Ebola Recovery Conference during which Commissioner Christos Stylianides announced €450 million to support the recovery of the three countries most affected by Ebola - Guinea, Sierra Leone and Liberia.


More News...